|C-reactive protein: a critical update|
MB Pepys, GM Hirschfield
The Journal of clinical investigation 111 (12), 1805-1812, 2003
|C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease|
J Danesh, JG Wheeler, GM Hirschfield, S Eda, G Eiriksdottir, A Rumley, ...
New England journal of medicine 350 (14), 1387-1397, 2004
|The gut microbiota and host health: a new clinical frontier|
JR Marchesi, DH Adams, F Fava, GDA Hermes, GM Hirschfield, G Hold, ...
Gut 65 (2), 330-339, 2016
|A placebo-controlled trial of obeticholic acid in primary biliary cholangitis|
F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ...
New England Journal of Medicine 375 (7), 631-643, 2016
|EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis|
GM Hirschfield, U Beuers, C Corpechot, P Invernizzi, D Jones, M Marzioni, ...
Journal of hepatology 67 (1), 145-172, 2017
|Targeting C-reactive protein for the treatment of cardiovascular disease|
MB Pepys, GM Hirschfield, GA Tennent, J Ruth Gallimore, MC Kahan, ...
Nature 440 (7088), 1217-1221, 2006
|Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants|
GM Hirschfield, X Liu, C Xu, Y Lu, G Xie, Y Lu, X Gu, EJ Walker, K Jing, ...
New England Journal of Medicine 360 (24), 2544-2555, 2009
|Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid|
GM Hirschfield, A Mason, V Luketic, K Lindor, SC Gordon, M Mayo, ...
Gastroenterology 148 (4), 751-761. e8, 2015
|Primary sclerosing cholangitis|
GM Hirschfield, TH Karlsen, KD Lindor, DH Adams
The Lancet 382 (9904), 1587-1599, 2013
|Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma|
JC Chambers, W Zhang, J Sehmi, X Li, MN Wass, P Van der Harst, ...
Nature genetics 43 (11), 1131-1138, 2011
|Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue|
KM Boberg, RW Chapman, GM Hirschfield, AW Lohse, MP Manns, ...
Journal of hepatology 54 (2), 374-385, 2011
|Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study|
WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ...
Gastroenterology 147 (6), 1338-1349. e5, 2014
|Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis|
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
|Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis|
TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ...
Gastroenterology 152 (8), 1975-1984. e8, 2017
|C-reactive protein and cardiovascular disease: new insights from an old molecule|
GM Hirschfield, MB Pepys
Qjm 96 (11), 793-807, 2003
|Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy|
WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ...
Gastroenterology 149 (7), 1804-1812. e4, 2015
|Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis|
JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ...
Nature genetics 45 (6), 670-675, 2013
|Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis|
T Kumagi, M Guindi, SE Fischer, T Arenovich, R Abdalian, C Coltescu, ...
Official journal of the American College of Gastroenterology| ACG 105 (10 …, 2010
|The immunobiology and pathophysiology of primary biliary cirrhosis|
GM Hirschfield, ME Gershwin
Annual review of pathology: Mechanisms of disease 8, 303-330, 2013
|The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis|
M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ...
Hepatology 63 (3), 930-950, 2016